ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 728133 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 728133; 2) Community: the network communities that were significantly associated with the response to NSC 728133; 3) Molecule: the relationships between components within communities and NSC 728133; 4) MDR: the compounds that were significantly associated with the NSC 728133.

NSC Compound Enrichment Correlation
NSC 95448 1H-1,2,4-Triazole, 3-(4-diazo-4H-imidazol-5-yl)- 0.0352383000003056 0.39772965
NSC 128687 6H-Furo[2',3':4,5]oxazolo[3,2-a]pyrimidine-2-methanol, 2,3,3a,9a-tetrahydro-6-imino-3-(phosphonooxy)-, (2R-(2.alpha.,3.beta.,3a.beta.,9a.beta.))- (9CI) 0.0352383000003058 0.3777023
NSC 179074 Lead, bis[(2-cyanoethyl)cyclohexylcarbamodithioato-S,S']-, (T-4)- 0.0352383000003058 0.46625052
NSC 179940 Benzofurazan, 4-(4-methyl-1-piperazinyl)-7-nitro-, 3-oxide 0.0352383000003058 0.52399352
NSC 258812 N,N-Dimethyldaunomycin hydrochloride 0.0352383000003058 0.4595458
NSC 278619 L-Arabinose, 2-amino-4-[(2-amino-1-oxopropyl)amino]-2,4-dideoxy-, monohydrochloride 0.0352383000003058 -0.10131988
NSC 282159 EN 589 0.0352383000003058 0.17544402
NSC 294980 N,N-Bis(2-chloroethyl)-p-toluidine 0.0352383000003058 0.36034135
NSC 302991 Camptothecin Derivative 0.0352383000003058 0.26557169
NSC 46691 Null 0.0352383000003058 -0.084378835
Total:80  Current:57    [First] [Prev] [Next] [Last]